ClinicalTrials.gg
Not yet recruitingNCT07577726Updated Oct 23, 2026

Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery

An observational study in Postoperative Cognitive Complications, Delirium and Perioperative/Postoperative Complications, sponsored by University of Texas Southwestern Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by University of Texas Southwestern Medical Center · Observational

Updated Oct 23, 2026Start date movedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective observational cohort study of adult patients undergoing high-risk surgery at UT Southwestern Medical Center. The study acquires synchronized multimodal neuromonitoring data - including SedLine quantitative EEG (qEEG) extracted from standard-of-care clinical monitoring and, where deployed, Brain4Care (B4C) noninvasive intracranial dynamics data - and links these data to perioperative hemodynamic, medication, laboratory, procedural, and outcome variables. No alteration of routine clinical care occurs. The primary goal is to characterize associations between monitor-derived features and perioperative clinical variables, and to establish a multimodal dataset supporting future analyses of perioperative brain health in high-risk surgical populations.

Read the detailed description

BACKGROUND: Patients undergoing major spine surgery, liver transplantation, on-pump cardiac surgery, major vascular surgery, major thoracic surgery, major abdominal surgery, and neurosurgical craniotomy are exposed to substantial perioperative physiologic stress, including hemodynamic instability, blood loss, cardiopulmonary bypass, and procedure-specific periods of altered cerebral perfusion. Quantitative electroencephalography and noninvasive assessments of intracranial dynamics may provide complementary information about brain state and cerebrovascular physiology during these high-risk operations. However, the relationships between monitor-derived features and intraoperative events - including hypotension, anesthetic transitions, major surgical events, and postoperative outcomes - remain incompletely characterized.

DESIGN: Single-center prospective observational cohort study at UT Southwestern Medical Center. SedLine quantitative EEG data are extracted from standard-of-care clinical monitoring for all enrolled subjects. Brain4Care (B4C) noninvasive intracranial dynamics monitoring may additionally be placed as a research device depending on study workflow, patient characteristics, technical feasibility, and clinical context. Either monitoring configuration - SedLine alone or SedLine combined with B4C - constitutes a complete and valid study encounter.

The Moberg Clinical Platform (Moberg Analytics; FDA-cleared multimodal data integration system) serves as the primary data acquisition hub where deployed in the operating room, aggregating synchronized high-resolution physiologic waveforms alongside SedLine and B4C outputs. Where Moberg is unavailable, hemodynamic and physiologic variables are collected retrospectively from the Epic intraoperative anesthesia record.

MONITORING MODALITIES:

Research device placed specifically for this study (where deployed):

- Brain4Care (B4C) extensometry: skull-mounted noninvasive sensor recording cranial compliance-related waveform morphology (P2/P1 ratio, Time to Peak).

Standard-of-care clinical data recorded for research purposes:

  • SedLine (Masimo): 4-channel frontal quantitative EEG providing Patient State Index, Spectral Edge Frequency, and exportable raw EDF-format waveforms.
  • Moberg Clinical Platform: multimodal physiologic waveform integration including arterial blood pressure, SpO2, ECG, ventilator-derived parameters, temperature, and EtCO2.

DATA MANAGEMENT: Subjects are assigned unique study identifiers. Direct identifiers are removed from analytic datasets. Research data are stored on secure, institutionally approved systems accessible only to IRB-authorized study personnel. De-identified data may be shared with qualified external collaborators under executed data use agreements.

02

Conditions studied

  • Postoperative Cognitive Complications
  • Delirium
  • Perioperative/Postoperative Complications
  • Brain Injuries
  • Anesthesia

Keywords

  • quantitative EEG
  • SedLine
  • Brain4Care
  • intracranial dynamics
  • cerebrovascular reactivity
  • perioperative neuromonitoring
  • postoperative delirium
  • perioperative brain health
  • cardiac surgery
  • liver transplantation
  • spine surgery
  • Moberg Clinical Platform
  • cerebral autoregulation
  • high-risk surgery
  • intraoperative monitoring
03

In context

Postoperative Cognitive Complications

260 studies on the registry are indexed under Postoperative Cognitive Complications; 55 are open to participants now.

This study's planned enrollment of 300 is above the median of 100 across 113 observational studies indexed under Postoperative Cognitive Complications.

Browse Postoperative Cognitive Complications studies →

Lead sponsor

University of Texas Southwestern Medical Center is the lead sponsor of 1,010 studies on the registry; 199 are open to participants now.

Of its 139 completed or terminated interventional studies of FDA-regulated products, 105 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients age 18 years or older scheduled to undergo major spine surgery, liver transplantation, on-pump cardiac surgery, major vascular surgery, major thoracic surgery, major abdominal surgery, or neurosurgical craniotomy at UT Southwestern Medical Center. These populations were selected because they commonly experience substantial perioperative hemodynamic and physiologic perturbations.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Scheduled to undergo major spine surgery, liver transplantation, on-pump cardiac surgery, major vascular surgery, major thoracic surgery, major abdominal surgery, or neurosurgical craniotomy at UT Southwestern Medical Center
  • Able to provide (self or legally authorized representative when applicable)
  • Safe and feasible placement of SedLine and/or Brain4Care monitoring as determined by the clinical and research teams
  • Anticipated availability of perioperative clinical data needed for study analyses

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years
  • Prisoner status
  • Pregnancy
  • Unable to provide in English (consent documents available in English only)
  • Declining participation
  • Lack of subject or legally authorized representative consent when required
  • Clinical condition preventing safe or feasible placement of study monitors (e.g., incompatible surgical field location, significant facial or scalp injury, open wounds at intended sensor placement site)
  • Operative workflow or clinical urgency precluding reasonable completion of consent and monitor placement prior to start of surgery
  • Anticipated clinical data capture insufficient for meaningful analysis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • High-Risk Surgical Patients

    Adult patients age 18 years or older undergoing major spine surgery, liver transplantation, on-pump cardiac surgery, major vascular surgery, major thoracic surgery, major abdominal surgery, or neurosurgical craniotomy at UT Southwestern Medical Center. All participants undergo SedLine qEEG data capture from existing standard-of-care clinical monitoring. A subset additionally undergo B4C noninvasive intracranial dynamics monitoring as a research device.

06

What researchers measure

Primary outcomes

  1. Proportion of enrolled cases with analyzable SedLine quantitative EEG (Patient State Index) recording during surgery

    Percentage of total enrolled cases yielding analyzable SedLine Patient State Index (PSI) epochs during the intraoperative period. Signal quality assessed by artifact burden and data completeness. Reported as a single proportion (percentage of cases with analyzable PSI data) across surgical case types.

    Time frame: Intraoperative period (duration of surgery, typically 2-12 hours)

  2. Proportion of enrolled cases with analyzable Brain4Care extensometry (P2/P1 ratio) recording during surgery

    Percentage of total enrolled cases yielding analyzable Brain4Care (B4C) extensometry P2/P1 ratio epochs during the intraoperative period. Signal quality assessed by artifact burden and adequate waveform morphology. Reported as a single proportion (percentage of cases with analyzable B4C data) across surgical case types.

    Time frame: Intraoperative period (duration of surgery, typically 2-12 hours)

  3. Correlation between SedLine Patient State Index and intraoperative mean arterial pressure

    Spearman correlation coefficient between SedLine-derived Patient State Index (PSI) values and concurrently recorded intraoperative mean arterial pressure. Secondary within-case correlation analyses with vasoactive drug administration epochs, anesthetic transitions, blood loss events, and major surgical epochs will also be reported as correlation coefficients.

    Time frame: Intraoperative period through 90 days post-surgery

  4. Correlation between Brain4Care extensometry P2/P1 ratio and intraoperative mean arterial pressure

    Spearman correlation coefficient between Brain4Care (B4C) extensometry-derived P2/P1 ratio values and concurrently recorded intraoperative mean arterial pressure. Secondary within-case correlation analyses with vasoactive drug administration epochs, anesthetic transitions, blood loss events, and major surgical epochs will also be reported as correlation coefficients.

    Time frame: Intraoperative period through 90 days post-surgery

Secondary outcomes

  1. Incidence of postoperative delirium assessed by Confusion Assessment Method (CAM)

    Rate of postoperative delirium as documented by Confusion Assessment Method (CAM) assessments in nursing records during the postoperative hospital stay, reported as incidence (percentage of enrolled patients with at least one positive CAM screen). Secondary analyses will examine associations between intraoperative SedLine PSI or B4C P2/P1 ratio features and postoperative delirium occurrence.

    Time frame: In-hospital postoperative period (expected 2-14 days post-surgery)

  2. Proportion of cases with computable cerebrovascular reactivity indices from Brain4Care extensometry and arterial blood pressure data

    Percentage of enrolled cases in which cerebrovascular reactivity-related indices can be computed from acquired Brain4Care (B4C) extensometry waveforms and concurrent arterial blood pressure data, reported as a single proportion with characterization of index distributions across surgical populations.

    Time frame: Intraoperative period

  3. Functional status at 90 days post-surgery assessed by modified Rankin Scale via medical record review

    Functional and neurological status assessed by modified Rankin Scale (mRS) score via medical record review and/or structured contact at up to 90 days from date of surgery. Reported as ordinal mRS score (0-6).

    Time frame: 90 days post-surgery

07

Study locations

1 site
  • UT Southwestern Medical Center - Clements University Hospital
    Dallas, Texas 75390, United States
    • Noah Jouett, DO, PhD · ContactNoah.Jouett@UTSouthwestern.edu · 2147862783
    • Noah Jouett, DO, PhD · Principal investigator
    • Ulrike Hoffmann, MD, PhD · Sub investigator
    • Peiman Lahsaei, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Start date
Jul 2026→Jul 2027
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Start date Jul 2026→Jul 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07577726
Responsible party
Noah Jouett (Principal Investigator, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center) — Principal investigator
First posted
May 11, 2026
Start date
Jul 2027 (estimated)
Primary completion
Jun 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Oct 23, 2026

Study contacts

Noah Jouett, DO, PhD
Contact
Noah.Jouett@UTSouthwestern.edu
2147862783
Noah Jouett, DO, PhD
principal investigator · University of Texas Southwestern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion